Ascendis Pharma price target raised to $162 from $153 at TD Cowen
TD Cowen analyst Yaron Werber raised the firm’s price target on Ascendis Pharma (ASND) to $162 from $153 and keeps a Buy rating on the shares.
Ascendis Pharma price target lowered to $192 from $203 at BofA
BofA lowered the firm’s price target on Ascendis Pharma (ASND) to $192 from $203 and keeps a Buy rating on the shares. After Ascendis provided ...